Stock screenerAll disclosures →
EDGAR →
STRO
Conviction 22HealthcareScan · Tue, Sep 8, 2026Inverted hammer
STRO$19.13-4.68%
ResistanceSupportVol 14Vol MA14 156.3K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price19.13
Change-4.68%
Gap-4.29%
Rel volume0.63×
Avg volume281.05K
Avg $ vol5.96M
SMA 2021.15
SMA 5024.36
SMA 20021.96
Price vs 50-21.48%
Price vs 200-12.89%
MA stackmixed
50/200 cross—
Supertrenddown · 23.47
RSI (14)33
MACD hist0.01
MACD crossbull · 8d
Stoch %K / %D1 / 14
ADX (14)41
+DI / −DI10 / 31
RSI divergenceBullish
MACD divergenceBullish
ATR %+7.87%
ADR %7.15%
52w high40.91
52w low0.7298
From 52w high-53.24%
Above 52w low+2521.27%
New 52w highNo
SqueezeOn · 1d
Bollinger width21.74%
%B0.06
Donchian pos10.18%
Donchian high25.88
Donchian low18.37
AVWAP (52w high)27.03
vs AVWAP high-29.24%
AVWAP (52w low)24.28
vs AVWAP low-21.20%
OBV trendDown
Chaikin MF (20)-0.02
Today vs 20d0.63×
Avg vol (14d)156.3K
Avg vol (20d)281.05K
Avg $ vol (20d)5.96M
Market cap317.2M
RS 3m (vs SPY)-27.50%
RS 6m (vs SPY)-35.19%
RS line new highNo
Trend template3/8
Technical rank10.4
1 week-5.48%
1 month-24.63%
3 months-24.71%
6 months-23.42%
1 year+1704.72%
YTD+74.54%
P/E-1.66
P/B-3.07
P/S3.10
P/FCF-1.77
EPS-22.49
Div yield—
ROE184.95%
ROA-98.26%
Debt/Eq-0.04
Current3.32
EV/EBITDA-1.77
Gross margin—
Net margin-186.45%
Rev growth65.18%
EPS growth15.99%
Price target51.17
Target upside167.49%
Analyst ratingBuy
Institutional101.84%
Ent. value266.92M
Revenue9.84M
Net income-38.53M
Gross profit—
Free cash flow-178.79M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out16.57M
Employees133
ListedThu, Sep 27, 2018
Free float15.56M
Float %93.9%
Short interest1.86M
Days to cover5.4d
Short volume56.6%
Squeeze score60 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$2.33 vs −$2.04
Last surprise-14.2% miss
Setup gradeD
Conviction22 / 100
Pattern quality—
Tech rank10.4 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmInverted hammer
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in STRO
No recent disclosed trades by Congress in STRO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in STRO · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hunter Heidi Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Petree Daniel H Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
MATSUI CONNIE Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Jagpal Sukhi Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
PANEK JAMES P Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Wigginton Jon Marc Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Dybbs Michael Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Lobacki Joseph M Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Chow Gregory K. CFO · Restricted Stock Units (RSUs) · 2026-06-02 | Exercise | 2.5K | $0 | 2026-06-02 | 2026-06-02 |
Chow Gregory K. CFO · Common Stock · 2026-06-02 | Exercise | 2.5K | $0 | 2026-06-02 | 2026-06-02 |
SEC filings
EDGAR filings in STRO · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.